- Telehealth Visits
- Insurances Accepted
Wei Z. Ai, MD, PhD
Hematology and Medical Oncology • Hematology and Medical Oncology (Lymphoma)- Telehealth Visits
- Insurances Accepted
Wei Z. Ai, MD, PhD
Hematology and Medical Oncology • Hematology and Medical Oncology (Lymphoma)- Telehealth Visits
- Insurances Accepted
On this page
About me
Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation.
In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level.
Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford.
Education
Board Certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
Fellowship
- Stanford University Medical Center-GME
- Oncology, UCSF School of Medicine -GME
Residency
- Internal Medicine, UCSF School of Medicine -GME
School
- MD, Stanford University
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Hematology and Medical Oncology
- Hematology and Medical Oncology (Lymphoma)
- Blood and Marrow Transplant and Cellular Therapy
Conditions
- Myelodysplastic Syndrome
- Chronic Lymphocytic Leukemia
Treatments
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Blood and Bone Marrow Transplant
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Clinical trials
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaOpens in a new window
Recruiting
Time from first study treatment to first occurrence of progression (as assessed by the Independent Review Committee) or death, whichever occurs first
Publications
Showing 1-6 of 67 reviews
- July 28, 20265 out of 5 Stars
Dr Ai is extraordinary. She has outstanding technical knowledge, skill, and creativity. Most importantly, she genuinely cares about me. I feel joy each time we meet, regardless of my condition. I am grateful to have her with me.
- July 7, 20265 out of 5 Stars
Dr. Ai is absolutely the best! She takes her time to listen to our concerns. Answers all our concerns and questions. She fully answers all your questions and she does not rush the appointment. You feel truly heard and validated. She has your undivided attention. Awesome doctor
- June 1, 20265 out of 5 Stars
Dr. Ai always puts me at ease. Explains in details treatments. Overall has a pacifying effect on me
- May 16, 20265 out of 5 Stars
Dr. Ai is the reason I continue treatment at UCSF. She's exceptional in every aspect.
- May 14, 20265 out of 5 Stars
Dr, Ai is simply the best oncologist
- May 14, 20265 out of 5 Stars
I cannot begin to explain how incredible Dr. Ai is in every aspect of her work. I'm am blessed by having her as my physician.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.